QuantiFERON-TB Gold Plus: Is your practice up-to-date?

Responsive image

Thank you

Thank you for your interest in QIAGEN microbiome workflow solutions.
A sales representative will contact you soon with your tailored discount offer.

Register here to watch the webinar today!

First Name*

Last Name*

Email address *

City*

State or Province*

Country*

Zip or Postal Code

Organization*

Job Profession*

Are you using QuantiFERON^®^-TB Gold Plus an Interferon-gamma release assay (IGRA)?*

Yes, I am using QFT-Plus

No, I am using a different TB assay

I want to be the first to hear about offers and news from QIAGEN. *

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

BANT_Budget*

For SP creation / could be hidden field

BANT_Authority*

For SP creation / could be hidden field

BANT_Need*

For SP creation / could be hidden field

BANT_Time*

For SP creation / could be hidden field

Product Line Interest

Primary Campaign Source

For SP creation / could be hidden field

Specific Interest

Lead Source - Most Recent*

For SP creation / could be hidden field

Interaction Request*

For SP creation / could be hidden field

Opportunity Type*

For SP creation / could be hidden field

Buying Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

Instrument Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

QuantiFERON-TB Gold Plus: Is your practice up-to-date?

IGRAs are the preferred test for the detection of latent TB Infection (LTBI) in most national guidelines for BCG-vaccinated persons in low-burden TB countries and is also endorsed by the WHO as an alternative to the TB skin test. QFT-Plus is the current standard for vaccine, pharmaceutical and latent TB infection (LTBI) research. Since the launch of QFT-Plus, which includes novel CD8 antigens, there is new research indicating their value in improving sensitivity in high risk groups, including those who are immunocompromised, in providing a more comprehensive picture of a patient’s immune response to TB.

After this webinar, you will have further understanding on:

Why to test and treat LTBI, the screening algorithm and LTBI
The new literature on QFT-Plus and how it performs in high-risk populations
New case studies and practical application using QFT-Plus

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to- date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.

+ Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws, including the EU General Data Protection Regulation. For further details, please refer to our Privacy Policy.